Will India Follow America’s GLP-1 Boom?

India’s falling GLP-1 drug prices will boost adoption, but regulation, affordability, and healthcare structure will prevent U.S.-style mass usage.

The Coming Wave of Weight-Loss Drugs: What India's GLP-1 Patent Cliff Means...

India's 2026 GLP-1 patent expiry will make weight-loss drugs affordable. Learn about benefits, risks, and what young adults need to know. Published by Research Realm

India’s First Confirmed Pufferfish Poisoning Raises Alarm!

A man in Gujarat suffered tetrodotoxin poisoning from freshwater pufferfish, exposing a hidden riverine health threat and lack of fish toxin monitoring.

Doctors say do THESE tests every 6 months - even if nothing...

Feeling fine isn’t enough. These six routine health tests help detect silent problems early and protect long-term health.